Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Domestic mutual funds overtake FPIs as anchor investors in IPOs: Prime Database
Swarup Mohanty, Vice Chairman & CEO of Mirae Asset Mutual Fund and Pranav Haldea, MD of Prime Database Group explain why mutual funds are becoming more selective, what is driving IPO participation, and how a record pipeline of ₹5 lakh crore worth of IPOs could shape the market.
Blue Jet Healthcare shares rally 9% after Rs 800 crore QIP allotment
Blue Jet Healthcare shares rose sharply on Friday after the company completed its Rs 800 crore QIP, attracting marquee institutional investors, including multiple ICICI Prudential Mutual Fund schemes. The fund raise is expected to strengthen the company's balance sheet, support expansion plans, and boost long-term growth prospects while broadening its institutional shareholder base.

Gold price falls, silver trades flat on MCX amid increased US Fed rate-hike bets
MCX gold August delivery was 0.27% down at ₹1,44,913 per 10 grams, while MCX silver September contracts were 0.08% up at ₹2,26,555 per kg around 9:15 am.

Gold Price Today: MCX Gold Trades Lower At Rs 1.44 Lakh As US-Iran Tensions Continue
MCX gold August futures contract dipped 0.26% to Rs 1,44,916 per 10 grams, while the MCX silver September futures rose 0.05% to Rs 2,26,500 per kg.

Gold, silver prices today: Why bullion remains volatile this week
Gold and silver prices fall amid West Asia tensions, Fed policy uncertainty. Geopolitical risks, crude oil, and US economic data drive volatility.
Stocks in news: TCS, Groww, Shriram Finance, Dixon Tech, Anand Rathi Wealth
Indian markets saw a rebound on Thursday, recovering from Wednesday's sharp sell-off. TCS reported a 5% year-on-year profit growth, and Groww affirmed its direct mutual fund strategy. Shriram Finance is raising funds to reduce borrowing costs after a rating upgrade. Maruti Suzuki plans to add service points, and Dixon Tech will expand smartphone manufacturing. Premier Energies commissioned a solar module facility, and Anand Rathi Wealth saw profit rise.

Groww says direct mutual funds remain core offering amid confusion over MF Prime
The investment platform clarified that its new MF Prime service is an optional offering for investors seeking research-backed guidance and does not replace its zero-commission direct mutual fund platform.
Groww responds to Nithin Kamath tweet: Direct mutual funds remain free for DIY investors
Groww assures investors direct mutual funds remain free for do-it-yourself users. The platform stated its commitment to zero-commission offerings for these investors. This clarification follows recent discussions regarding mutual fund offerings in the market.
Zerodha will keep direct mutual fund plans for free, says Nithin Kamath
Zerodha founder Nithin Kamath reaffirmed the company’s commitment to offering direct mutual funds free of charge. He said Coin has helped investors save commissions, while many rival platforms have exited or reconsidered the low-cost direct mutual fund business model.

'Disappeared Or Pivoted': Nithin Kamath Takes Swipe As Groww Shifts To Regular MFs
Kamath defends direct MFs as Groww expands into regular mutual fund offerings.

One nation, one KYC could unlock the next phase of mutual fund growth, says SBI Funds
DP Singh, Joint CEO and RS Srinivas Jain, Executive President & Chief of Strategy at SBI Funds Management discuss how simpler onboarding could bring millions of new investors into mutual funds, the huge growth opportunity within SBI's customer base, rising SIP inflows, the shift towards higher-margin active equity funds, and the company's long-term growth outlook.

Banks and insurance are the bright spots, says Quantum AMC's Christy Mathai
Christy Mathai, Fund Manager at Quantum AMC, says most companies' input cost pressures will show up in quarter two rather than quarter one, as firms are still using cheaper stockpiled materials to protect margins. He expects a broader earnings recovery from the second half of the year, provided tensions in West Asia don't escalate further. Mathai is upbeat on private banks and life insurance, cautiously positive on select pharma names with US exposure, but is steering clear of chemical and defence stocks over stretched valuations. Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.